Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

VYNE Therapeutics Inc. (VYNE)

0.6891   0.002 (0.29%) 01-19 08:58
Open: 0.7101 Pre. Close: 0.6871
High: 0.723 Low: 0.68
Volume: 1,519,636 Market Cap: 37M
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age and older; and ZILXI for the treatment of inflammation lesions of papulopustular rosacea in adults. It is also developing FCD105, a topical combination foam that has completed Phase II clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in preclinical trial for the treatment of mild-to-moderate atopic dermatitis. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.722 - 0.726 0.726 - 0.729
Low: 0.668 - 0.674 0.674 - 0.678
Close: 0.682 - 0.69 0.69 - 0.697

Technical analysis

as of: 2022-01-19 8:56:30 AM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.20     One year: 1.47
Support: Support1: 0.65    Support2: 0.54
Resistance: Resistance1: 1.03    Resistance2: 1.26
Pivot: 0.96
Moving Average: MA(5): 0.77     MA(20): 0.99
MA(100): 1.24     MA(250): 3.56
MACD: MACD(12,26): -0.10     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 6.89     %D(3): 6.53
RSI: RSI(14): 29.40
52-week: High: 13.20  Low: 0.65  Change(%): -93.5
Average Vol(K): 3-Month: 292764  10-Days: 286812

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
VYNE has closed above bottom band by 6.7%. Bollinger Bands are 52.8% wider than normal. The large width of the bands suggest high volatility as compared to VYNE's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Tue, 18 Jan 2022
52 Biggest Movers From Friday - Benzinga - Benzinga

Mon, 17 Jan 2022
VYNE Therapeutics Inc Shares Close the Week 32.6% Lower - Weekly Wrap - Nasdaq

Fri, 14 Jan 2022
VYNE THERAPEUTICS INC. Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K/A) - marketscreener.com

Fri, 14 Jan 2022
NASDAQ Under $2 Most Active: RMTI, SNDL, PETZ, XELA, VYNE - Top News Guide - Top News Guide

Thu, 13 Jan 2022
Health Care Sector Update for 01/13/2022: VYNE,DERM,DNLI,PCVX,BBLN - Nasdaq

Thu, 13 Jan 2022
VYNE Therapeutics Divests Topical Minocycline Assets - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 54
Shares Float (M) 52
% Held by Insiders 3.02
% Held by Institutions 29.69
Shares Short (K) 2,080
Shares Short P. Month (K) 822

Stock Financials

EPS -1.746
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 1.100
Profit Margin
Operating Margin -368.84
Return on Assets (ttm) -40.9
Return on Equity (ttm) -156.7
Qtrly Rev. Growth 25.0
Gross Profit (p.s.) 0.366
Sales Per Share 0.313
EBITDA (p.s.) -1.151
Qtrly Earnings Growth
Operating Cash Flow (M) -72
Levered Free Cash Flow (M) -36

Stock Valuations

PE Ratio -0.39
PEG Ratio
Price to Book value 0.63
Price to Sales 2.20
Price to Cash Flow -0.51

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.